Russell E. McDaniel
Impact in
- Equine top 5%
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
- Co-authors
- Philipp Y. Maximov (10 shared papers)V. Craig Jordan (9 shared papers)Ping Fan (5 shared papers)Fadeke A. Agboke (4 shared papers)Elizabeth E. Sweeney (2 shared papers)V. Craig Jordan (4 shared papers)Karen Creswell (2 shared papers)Bradley Whitehead (1 shared paper)
- Journals
- European Journal of Cancer (2 papers)Cancer Research (2 papers)Molecular Cancer Research (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Vitamins and hormones (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Russell E. McDaniel
15 papers receiving 412 citations
Peers
Comparison fields: 5 of 75
- Equine 18
- Toxicology 28
- Genetics 187
- Pharmacology 42
- Oncology 105
Countries citing papers authored by Russell E. McDaniel
This map shows the geographic impact of Russell E. McDaniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell E. McDaniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell E. McDaniel more than expected).
Fields of papers citing papers by Russell E. McDaniel
This network shows the impact of papers produced by Russell E. McDaniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell E. McDaniel. The network helps show where Russell E. McDaniel may publish in the future.
Co-authors
The 25 scholars most cited alongside Russell E. McDaniel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 72 | |
| 2 | 2013 | 70 | |
| 3 | 2012 | 70 | |
| 4 | 2013 | 36 | |
| 5 | 2012 | 29 | |
| 6 | 2015 | 27 | |
| 7 | 2014 | 25 | |
| 8 | 2014 | 24 | |
| 9 | 2014 | 20 | |
| 10 | 2014 | 15 | |
| 11 | 2013 | 11 | |
| 12 | 2013 | 10 | |
| 13 | 2013 | 9 | |
| 14 | 2012 | 2 | |
| 15 | 2016 | 1 |
About Russell E. McDaniel
Russell E. McDaniel is a scholar working on Genetics, Oncology, Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 15 papers that have together received 421 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (9 papers), Pharmacogenetics and Drug Metabolism (3 papers), Breast Cancer Treatment Studies (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), HER2/EGFR in Cancer Research (2 papers), Microbial infections and disease research (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Equine (18 citations), Toxicology (28 citations), Genetics (187 citations), Pharmacology (42 citations) and Oncology (105 citations). Russell E. McDaniel has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Philipp Y. Maximov, V. Craig Jordan, Ping Fan, Fadeke A. Agboke, Elizabeth E. Sweeney, V. Craig Jordan, Karen Creswell, Bradley Whitehead, Nicola Pusterla and Carlos Gutiérrez. Their work appears in journals such as European Journal of Cancer, Cancer Research, Molecular Cancer Research, JNCI Journal of the National Cancer Institute and Vitamins and hormones.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.